Rutinosides-derived from Sarocladium strictum 6-O-α-rhamnosyl-β-glucosidase show enhanced anti-tumoral activity in pancreatic cancer cells.
Diglycosidases
Glycoconjugates
Pancreatic cancer
Therapeutics
Transglycosylation
Journal
Microbial cell factories
ISSN: 1475-2859
Titre abrégé: Microb Cell Fact
Pays: England
ID NLM: 101139812
Informations de publication
Date de publication:
08 May 2024
08 May 2024
Historique:
received:
17
01
2024
accepted:
16
04
2024
medline:
9
5
2024
pubmed:
9
5
2024
entrez:
9
5
2024
Statut:
epublish
Résumé
Low targeting efficacy and high toxicity continue to be challenges in Oncology. A promising strategy is the glycosylation of chemotherapeutic agents to improve their pharmacodynamics and anti-tumoral activity. Herein, we provide evidence of a novel approach using diglycosidases from fungi of the Hypocreales order to obtain novel rutinose-conjugates therapeutic agents with enhanced anti-tumoral capacity. Screening for diglycosidase activity in twenty-eight strains of the genetically related genera Acremonium and Sarocladium identified 6-O-α-rhamnosyl-β-glucosidase (αRβG) of Sarocladium strictum DMic 093557 as candidate enzyme for our studies. Biochemically characterization shows that αRβG has the ability to transglycosylate bulky OH-acceptors, including bioactive compounds. Interestingly, rutinoside-derivatives of phloroglucinol (PR) resorcinol (RR) and 4-methylumbelliferone (4MUR) displayed higher growth inhibitory activity on pancreatic cancer cells than the respective aglycones without significant affecting normal pancreatic epithelial cells. PR exhibited the highest efficacy with an IC αRβG from S. strictum transglycosylate-based approach to synthesize rutinosides represents a suitable option to enhance the anti-proliferative effect of bioactive compounds. This finding opens up new possibilities for developing more effective therapies for pancreatic cancer and other solid malignancies.
Sections du résumé
BACKGROUND
BACKGROUND
Low targeting efficacy and high toxicity continue to be challenges in Oncology. A promising strategy is the glycosylation of chemotherapeutic agents to improve their pharmacodynamics and anti-tumoral activity. Herein, we provide evidence of a novel approach using diglycosidases from fungi of the Hypocreales order to obtain novel rutinose-conjugates therapeutic agents with enhanced anti-tumoral capacity.
RESULTS
RESULTS
Screening for diglycosidase activity in twenty-eight strains of the genetically related genera Acremonium and Sarocladium identified 6-O-α-rhamnosyl-β-glucosidase (αRβG) of Sarocladium strictum DMic 093557 as candidate enzyme for our studies. Biochemically characterization shows that αRβG has the ability to transglycosylate bulky OH-acceptors, including bioactive compounds. Interestingly, rutinoside-derivatives of phloroglucinol (PR) resorcinol (RR) and 4-methylumbelliferone (4MUR) displayed higher growth inhibitory activity on pancreatic cancer cells than the respective aglycones without significant affecting normal pancreatic epithelial cells. PR exhibited the highest efficacy with an IC
CONCLUSIONS
CONCLUSIONS
αRβG from S. strictum transglycosylate-based approach to synthesize rutinosides represents a suitable option to enhance the anti-proliferative effect of bioactive compounds. This finding opens up new possibilities for developing more effective therapies for pancreatic cancer and other solid malignancies.
Identifiants
pubmed: 38720294
doi: 10.1186/s12934-024-02395-0
pii: 10.1186/s12934-024-02395-0
doi:
Substances chimiques
Antineoplastic Agents
0
rutinose
0C4U3505G3
Rutin
5G06TVY3R7
Gemcitabine
0
Disaccharides
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
133Informations de copyright
© 2024. The Author(s).
Références
Stuurman FE, Nuijen B, Beijnen JH, Schellens JHM. Oral anticancer drugs: mechanisms of low bioavailability and strategies for improvement. Clin Pharmacokinet. 2013;52(6):399–414.
pubmed: 23420518
doi: 10.1007/s40262-013-0040-2
Ioele G, Chieffallo M, Occhiuzzi MA, Ragno G, Grande F, De LM, et al. Pharmacokinetic and pharmacodynamic properties. Molecules. 2022;27(17):5436.
pubmed: 36080203
pmcid: 9457551
doi: 10.3390/molecules27175436
Iglesias LE, Lewkowicz ES, Medici R, Bianchi P, Iribarren AM. Biocatalytic approaches applied to the synthesis of nucleoside prodrugs. Biotechnol Adv. 2015;33(5):412–34.
pubmed: 25795057
doi: 10.1016/j.biotechadv.2015.03.009
Agarwal R, Agarwal C, Ichikawa H, Singh RP, Aggarwal BB. Anticancer potential of silymarin: from bench to bed side. Anticancer Res. 2006;26(6B):4457–98.
pubmed: 17201169
Martin H, Lázaro LR, Gunnlaugsson T, Scanlan EM. Glycosidase activated prodrugs for targeted cancer therapy. Chem Soc Rev. 2022;51(23):9694–716.
pubmed: 36349720
doi: 10.1039/D2CS00379A
Molejon MI, Weiz G, Breccia JD, Vaccaro MI. Glycoconjugation: an approach to cancer therapeutics. World J Clin Oncol. 2020;11(3):110–20.
pubmed: 32257842
pmcid: 7103525
doi: 10.5306/wjco.v11.i3.110
Chen F, Huang G. Application of glycosylation in targeted drug delivery. Eur J Med Chem. 2019;182: 111612.
pubmed: 31421631
doi: 10.1016/j.ejmech.2019.111612
Cai L, Gu Z, Zhong J, Wen D, Chen G, He L. Advances in glycosylation-mediated cancer-targeted drug delivery. Drug Discov Today. 2018;23(5):1126–38.
pubmed: 29501708
doi: 10.1016/j.drudis.2018.02.009
Shaul P, Steinbuch KB, Blacher E, Stein R, Fridman M. Exploring the effects of glycosylation and etherification of the side chains of the anticancer drug mitoxantrone. ChemMedChem. 2015;10(9):1528–38.
pubmed: 26235383
doi: 10.1002/cmdc.201500274
Biocatalysis S, Pyser JB, Chakrabarty S, Romero EO, Narayan ARH. State-of-the-art biocatalysis. ACS cent Sci. 2021;7(7):1105–16.
doi: 10.1021/acscentsci.1c00273
Wu S, Snajdrova R, Moore JC, Baldenius K, Bornscheuer UT. Biocatalysis: enzymatic synthesis for industrial applications. Angew Chem Int Edition. 2021;60(1):88–119.
doi: 10.1002/anie.202006648
Danby PM, Withers SG. Advances in enzymatic glycoside synthesis. ACS Chem Biol. 2016;11(7):1784–94.
pubmed: 27176929
doi: 10.1021/acschembio.6b00340
Malik A, Seeberger PH, Varón SD. Advances in the chemical synthesis of carbohydrates and glycoconjugates. Adv Biochem Eng Biotechnol. 2021;175:201–30.
pubmed: 33188456
Andreotti G, Trincone A, Giordano A. Convenient synthesis of β-galactosyl nucleosides using the marine β-galactosidase from Aplysia fasciata. J Mol Catal B Enzymatic. 2007;47(1–2):28–32.
doi: 10.1016/j.molcatb.2007.03.006
Singh S, Aggarwal A, Dinesh NVS, Bhupathiraju K, Arianna G, Tiwari K, Drain CM. Glycosylated porphyrins, phthalocyanines, and other porphyrinoids for diagnostics and therapeutics. Chem Rev. 2015;115(18):10261–306.
pubmed: 26317756
pmcid: 6011754
doi: 10.1021/acs.chemrev.5b00244
Yan LQ, Li N, Zong MH. First and facile enzymatic synthesis of β-fucosyl-containing disaccharide nucleosides through β-galactosidase-catalyzed regioselective glycosylation. J Biotechnol. 2012;164(2):371–5.
pubmed: 23395673
doi: 10.1016/j.jbiotec.2013.01.024
Desmet T, Soetaert W, Bojarová P, Křen V, Dijkhuizen L, Eastwick-Field V, Schiller A. Enzymatic glycosylation of small molecules: challenging substrates require tailored catalysts. Chem Eur J. 2012;18(35):10786–801.
pubmed: 22887462
doi: 10.1002/chem.201103069
Ati J, Lafite P, Daniellou R. Enzymatic synthesis of glycosides: from natural O- and N-glycosides to rare C- and S-glycosides. Beilstein J Org Chem. 2017;13:1857–65.
pubmed: 29062404
pmcid: 5629408
doi: 10.3762/bjoc.13.180
Zuzana M, Nekvasilov P, Bojarov P, Vladimír K. Advanced glycosidases as ingenious biosynthetic instruments. Biotechnol Adv. 2021;49: 107733.
doi: 10.1016/j.biotechadv.2021.107733
Withers SG. Mechanisms of glycosyl transferases and hydrolases. Carbohydr Polym. 2001;44(4):325–37.
doi: 10.1016/S0144-8617(00)00249-6
Křen V, Bojarová P. Rutinosidase and other diglycosidases: rising stars in biotechnology. Biotechnol Adv. 2023; 108217.
Weiz G, Molejon MI, Malvicini M, Sukowati CHC, Mazzolini G, Breccia JD. Glycosylated 4-methylumbelliferone as a targeted therapy for hepatocellular carcinoma. Liv Int. 2022;42(2):444–57.
doi: 10.1111/liv.15084
Haluz P, Kis P, Cvečko M, Mastihubová M, Mastihuba V. Acuminosylation of tyrosol by a commercial diglycosidase. Int J Mol Sci. 2023;24(6):5943.
pubmed: 36983015
pmcid: 10059904
doi: 10.3390/ijms24065943
Bassanini I, Kapešová J, Petrásková L, Pelantová H, Markošová K, Rebroš M, et al. Glycosidase-catalyzed synthesis of glycosyl esters and phenolic glycosides of aromatic acids. Adv Synth Catal. 2019;361(11):2627–37.
doi: 10.1002/adsc.201900259
Šimčíková D, Kotik M, Weignerová L, Halada P, Pelantová H, Adamcová K, et al. α-L-Rhamnosyl-β-D-glucosidase (rutinosidase) from Aspergillus niger: characterization and synthetic potential of a novel diglycosidase. Adv Synth Catal. 2014;357(1):107–17.
doi: 10.1002/adsc.201400566
Mazzaferro LS, Weiz G, Braun L, Kotik M, Pelantová H, Křen V, et al. Enzyme-mediated transglycosylation of rutinose (6-O-α-l-rhamnosyl-D-glucose) to phenolic compounds by a diglycosidase from Acremonium sp. DSM 24697. Biotechnol Appl Biochem. 2019;66(1):53–9.
pubmed: 30294837
doi: 10.1002/bab.1695
Weiz G, Mazzaferro LS, Kotik M, Neher BD, Halada P, Křen V, et al. The flavonoid degrading fungus Acremonium sp. DSM 24697 produces two diglycosidases with different specificities. Appl Microbiol Biotechnol. 2019;103(23–24):9493–504.
pubmed: 31705182
doi: 10.1007/s00253-019-10180-y
Giraldo A, Gené J, Sutton DA, Madrid H, de Hoog GS, Cano J, et al. Phylogeny of Sarocladium (Hypocreales). Pers Mol Phylogeny Evol Fungi. 2015;34:10–24.
doi: 10.3767/003158515X685364
Mazzaferro LS, Piñuel L, Erra-Balsells R, Giudicessi SL, Breccia JD. Transglycosylation specificity of Acremonium sp. α-rhamnosyl-β-glucosidase and its application to the synthesis of the new fluorogenic substrate 4-methylumbelliferyl-rutinoside. Carbohydr Res. 2012;347(1):69–75.
pubmed: 22169180
doi: 10.1016/j.carres.2011.11.008
González C, Martinez A, Vázquez F, Baigorí M, de Figueroa LIC. New method of screening and differentiation of exoenzymes from industrial strains. Biotechnol Tech. 1996;10(7):519–22.
doi: 10.1007/BF00159517
Laemmli U. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;228:726–34.
Miller GL. Use of dinitrosaiicyiic acid reagent for determination of reducing sugar. Anal Chem. 1959;31(3):426–8.
doi: 10.1021/ac60147a030
Weiz G, Breccia JD, Mazzaferro LS. Screening and quantification of the enzymatic deglycosylation of the plant flavonoid rutin by UV–visible spectrometry. Food Chem. 2017;229:44–9.
pubmed: 28372198
doi: 10.1016/j.foodchem.2017.02.029
Fries AA, Mazzaferro L, Grüning B, Stibal K, Buchholz P, Pleiss J, et al. Alteration of the route to menaquinone towards isochorismate-derived metabolites. ChemBioChem. 2019;20(13):1672–7.
pubmed: 30866142
pmcid: 6618250
doi: 10.1002/cbic.201900050
Candiano G, Bruschi M, Musante L, Santucci L, Ghiggeri GM, Carnemolla B, et al. Blue silver: a very sensitive colloidal Coomassie G-250 staining for proteome analysis. Electrophoresis. 2004;25(9):1327–33.
pubmed: 15174055
doi: 10.1002/elps.200305844
Artimo P, Jonnalagedda M, Arnold K, Baratin D, Csardi G, De Castro E, et al. ExPASy: SIB bioinformatics resource portal. Nucleic Acids Res. 2012;40(W1):597–603.
doi: 10.1093/nar/gks400
Petersen TN, Brunak S, Von Heijne G, Nielsen H. SignalP 4.0: discriminating signal peptides from transmembrane regions. Nat Methods. 2011;8(10):785–6.
pubmed: 21959131
doi: 10.1038/nmeth.1701
Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, et al. Measurement of protein using bicinchoninic acid. Anal Biochem. 1985;150(1):76–85.
pubmed: 3843705
doi: 10.1016/0003-2697(85)90442-7
Loewe S, Muchnik H. Effect of combinations: mathematical basis of problem. Arch Exp Pathol Pharmacol. 1926;114:313–26.
doi: 10.1007/BF01952257
Qin Y, Lu H, Qi X, Lin M, Gao C. Recent advances in chemistry and bioactivities of secondary metabolites from the genus Acremonium. J Fungi. 2024;10(1):37.
doi: 10.3390/jof10010037
Mazzaferro LS, Breccia JD. Functional and biotechnological insights into diglycosidases*. Biocatal Biotransform. 2011;29(4):103–12.
doi: 10.3109/10242422.2011.594882
Pádua D, Rocha E, Gargiulo D, Ramos AA. Bioactive compounds from brown seaweeds: phloroglucinol, fucoxanthin and fucoidan as promising therapeutic agents against breast cancer. Phytochem Lett. 2015;14:91–8.
doi: 10.1016/j.phytol.2015.09.007
Kim RK, Uddin N, Hyun JW, Kim C, Suh Y, Lee SJ. Novel anticancer activity of phloroglucinol against breast cancer stem-like cells. Toxicol Appl Pharmacol. 2015;286(3):143–50.
pubmed: 25843036
doi: 10.1016/j.taap.2015.03.026
Kim RK, Suh Y, Yoo KC, Cui YH, Hwang E, Kim HJ, et al. Phloroglucinol suppresses metastatic ability of breast cancer cells by inhibition of epithelial–mesenchymal cell transition. Cancer Sci. 2015;106(1):94–101.
pubmed: 25456733
doi: 10.1111/cas.12562
Shahinozzaman M, Ishii T, Halim MA, Hossain MA, Islam MT, Tawata S. Cytotoxic and anti-inflammatory resorcinol and alkylbenzoquinone derivatives from the leaves of Ardisia sieboldii. Z Naturforsch C J Biosci. 2019;74(11–12):303–11.
pubmed: 31437126
doi: 10.1515/znc-2019-0114
Pibuel MA, Poodts D, Díaz M, Molinari YA, Franco PG, Hajos SE, et al. Antitumor effect of 4MU on glioblastoma cells is mediated by senescence induction and CD44, RHAMM and p-ERK modulation. Cell Death Discov. 2021;7(1):1–14.
doi: 10.1038/s41420-021-00672-0
Rodríguez MM, Fiore E, Bayo J, Atorrasagasti C, García M, Onorato A, et al. 4Mu decreases CD47 expression on hepatic cancer stem cells and primes a potent antitumor T cell response induced by interleukin-12. Mol Ther. 2018;26(12):2738–50.
pubmed: 30301668
pmcid: 6277513
doi: 10.1016/j.ymthe.2018.09.012
Nagase H, Kudo D, Suto A, Yoshida E, Suto S, Negishi M, et al. 4-Methylumbelliferone suppresses hyaluronan synthesis and tumor progression in SCID mice intra-abdominally inoculated with pancreatic cancer cells. Pancreas. 2017;46(2):190–7.
pubmed: 27846148
doi: 10.1097/MPA.0000000000000741
Ishikawa M, Kawasaki M, Shiono Y, Koseki T. A novel Aspergillus oryzae diglycosidase that hydrolyzes 6-O-α-L-rhamnosyl-β-D-glucoside from flavonoids. Appl Microbiol Biotechnol. 2018;102(7):3193–201.
pubmed: 29476400
doi: 10.1007/s00253-018-8840-9
Mazzaferro L, Piñuel L, Minig M, Breccia JD. Extracellular monoenzyme deglycosylation system of 7-O-linked flavonoid β-rutinosides and its disaccharide transglycosylation activity from Stilbella fimetaria. Arch Microbiol. 2010;192(5):383–93.
pubmed: 20358178
doi: 10.1007/s00203-010-0567-7
Kotik M, Jav H, Brodsky K, Pelantová H. Two fungal flavonoid-specific glucosidases/rutinosidases for rutin hydrolysis and rutinoside synthesis under homogeneous and heterogeneous reaction conditions. AMB Express. 2021;11:1–11.
doi: 10.1186/s13568-021-01298-2
Actis- Goretta L, Dew TP, Lévèques A, et al. Gastrointestinal absorption and metabolism of hesperetin-7-O-rutinoside and hesperetin-7-O-glucoside in healthy humans. Mol Nutr Food Res. 2015;59(9):1651–62.
pubmed: 26018925
doi: 10.1002/mnfr.201500202
Wang Y, Gao J, Gu G, Li G, Cui C, Sun B, et al. In situ RBL receptor visualization and its mediated anticancer activity for solasodine rhamnosides. ChemBioChem. 2011;12(16):2418–20.
pubmed: 21953983
doi: 10.1002/cbic.201100551
Xu L, Liu X, Li Y, Yin Z, Jin L, Lu L, et al. Enzymatic rhamnosylation of anticancer drugs by an α-L-rhamnosidase from Alternaria sp. L1 for cancer-targeting and enzyme-activated prodrug therapy. Appl Microbiol Biotechnol. 2019;103(19):7997–8008.
pubmed: 31414160
doi: 10.1007/s00253-019-10011-0
Xing JY, Song GP, Deng JP, Jiang LZ, Xiong P, Yang BJ, et al. Antitumor effects and mechanism of novel emodin rhamnoside derivatives against human cancer cells in vitro. PLoS ONE. 2015;10(12): e0144781.
pubmed: 26682731
pmcid: 4684281
doi: 10.1371/journal.pone.0144781
Pandita A, Kumar B, Manvati S, Vaishnavi S, Singh SK, Bamezai RNK. Synergistic combination of gemcitabine and dietary molecule induces apoptosis in pancreatic cancer cells and down regulates PKM2 expression. PLoS ONE. 2014;9(9):1–11.
doi: 10.1371/journal.pone.0107154
Majhi S. Recent developments in the synthesis and anti-cancer activity of acridine and xanthine-based molecules. Phys Sci Rev. 2023;8(9):2405–39.
Majhi S. Discovery, development and design of anthocyanins-inspired anticancer agents: a comprehensive review. Anticancer Agents Med Chem. 2022;22(19):3219–38.
pubmed: 34779372
doi: 10.2174/1871520621666211015142310
Majhi S, Das D. Chemical derivatization of natural products: semisynthesis and pharmacological aspects—a decade update. Tetrahedron. 2021;78: 131801.
doi: 10.1016/j.tet.2020.131801